PMA · Approved
Recalled · Class II · 2025Medtronic Interstim Sacral Nerve Stimulation Therapy System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Medtronic Neuromodulation · QON Implanted Electrical Device Intended For Treatment Of Fecal Incontinence
Approved on Mar 14, 2011 through premarket approval, which rests on the device’s own clinical evidence after an 899-day review. It has been recalled 5 times.
- Decided
- Mar 14, 2011
- Review
- 899 days
- Class
- Class III
- Product code
- QON
- Recalls
- 5
PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.
P080025 has 349 supplements since 2011: changes to the approved device, its labelling or its manufacturing, each approved separately.
PMA supplements approved per year
View FIG. 1 as a table
| Year | Supplements approved |
|---|---|
| 2011 | 21 |
| 2012 | 19 |
| 2013 | 17 |
| 2014 | 23 |
| 2015 | 20 |
| 2016 | 27 |
| 2017 | 27 |
| 2018 | 19 |
| 2019 | 23 |
| 2020 | 22 |
| 2021 | 19 |
| 2022 | 31 |
| 2023 | 17 |
| 2024 | 20 |
| 2025 | 25 |
| 2026 | 19 |
Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in QON? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
Does it have a predicate?
PMA decisions do not claim a predicate device.
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Apr 3, 2025 | Class II | Z-1704-2025 | Device Design | Evaluation handsets may not be able to communicate with the neurostimulator due to handsets having a faster processing speed than prior handsets. An inability to connect may cause the therapy to stop being delivered and a system error… |
| Sep 18, 2024 | Class II | Z-0372-2025 | Under Investigation by firm | The Wireless Rechargers in the kits may be unable to enter a recharging session upon first use. |
| Jul 6, 2023 | Class II | Z-2365-2023 | Under Investigation by firm | Lot of InterStim Self-Adhesive Ground Pad is being recalled due to the product being labeled with the incorrect expiration date. |
| Feb 28, 2022 | Class II | Z-0998-2022 | Software Design Change | There is a software anomaly with the InterStim X Clinician software application with results in the data entered in the Patient Information fields not e retained and a " Data Lost" notification being displayed. |
| Jan 9, 2015 | Class II | Z-1147-2015 | Other | Current labeling indicates that cycling improves device longevity in every programming scenario. However, enabling cycling at certain parameter settings may decrease the device battery longevity. With cycling enabled, longevity estimate… |
No ancestor or descendant has a Class I recall.
How does its category compare?
All QON devicesQON Implanted Electrical Device Intended For Treatment Of Fecal Incontinence: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.
FDA decisions per year · QON
34in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · QON
Too few QON 510(k)s in any year since 2007 to give a median.
Recalls per year · QON
1so far in 2026, the most since 2007
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · QON
2in 2025
MAUDE reports naming product code QON, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 22 | — | 0 | 0 |
| 2012 | 19 | — | 0 | 0 |
| 2013 | 17 | — | 0 | 0 |
| 2014 | 23 | — | 0 | 0 |
| 2015 | 20 | — | 0 | 0 |
| 2016 | 27 | — | 0 | 0 |
| 2017 | 27 | — | 0 | 0 |
| 2018 | 19 | — | 0 | 0 |
| 2019 | 25 | — | 0 | 0 |
| 2020 | 42 | — | 0 | 0 |
| 2021 | 34 | — | 0 | 0 |
| 2022 | 46 | — | 0 | 0 |
| 2023 | 31 | — | 0 | 2 |
| 2024 | 35 | — | 0 | 0 |
| 2025 | 34 | — | 0 | 2 |
| 2026 | 33 | — | 1 | — |
https://510kreport.com/device/P080025 · printed Nov 6, 2026
Cite this page
510(k) Report. “P080025: Medtronic Interstim Sacral Nerve Stimulation Therapy System.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P080025
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Page last updated Nov 3, 2026